Alexeeva, E.I.; Tsulukiya, I.T.; Dvoryakovskaya, T.M.; Kudlay, D.A.; Kriulin, I.A.; Botova, M.S.; Kondratyeva, N.M.; Krekhova, E.A.; Shingarova, M.S.; Kokina, M.Y.;
et al. Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. Biomedicines 2025, 13, 2329.
https://doi.org/10.3390/biomedicines13102329
AMA Style
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kudlay DA, Kriulin IA, Botova MS, Kondratyeva NM, Krekhova EA, Shingarova MS, Kokina MY,
et al. Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. Biomedicines. 2025; 13(10):2329.
https://doi.org/10.3390/biomedicines13102329
Chicago/Turabian Style
Alexeeva, Ekaterina I., Irina T. Tsulukiya, Tatyana M. Dvoryakovskaya, Dmitry A. Kudlay, Ivan A. Kriulin, Maria S. Botova, Natalya M. Kondratyeva, Elizaveta A. Krekhova, Meiri Sh. Shingarova, Maria Y. Kokina,
and et al. 2025. "Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center" Biomedicines 13, no. 10: 2329.
https://doi.org/10.3390/biomedicines13102329
APA Style
Alexeeva, E. I., Tsulukiya, I. T., Dvoryakovskaya, T. M., Kudlay, D. A., Kriulin, I. A., Botova, M. S., Kondratyeva, N. M., Krekhova, E. A., Shingarova, M. S., Kokina, M. Y., Fetisova, A. N., Isaeva, K. B., Chomakhidze, A. M., Chibisova, C. V., & Kostik, M. M.
(2025). Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. Biomedicines, 13(10), 2329.
https://doi.org/10.3390/biomedicines13102329
